Chronopharmacology and Mechanism of Antitumor Effect of Erlotinib in Lewis Tumor-Bearing Mice

The epidermal growth factor receptor (EGFR), a ubiquitously expressed receptor tyrosine kinase, is recognized as a key mediator of tumorigenesis in many human epithelial tumors. Erlotinib is tyrosine kinase inhibitor approved by FDA for use in oncology. It inhibits the intracellular phosphorylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peipei, An, Fengmei, Zhuang, Xingjun, Liu, Jiao, Zhao, Liyan, Zhang, Bin, Liu, Liang, Lin, Pingping, Li, Mingchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085002/
https://www.ncbi.nlm.nih.gov/pubmed/25000529
http://dx.doi.org/10.1371/journal.pone.0101720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085002/
https://www.ncbi.nlm.nih.gov/pubmed/25000529
http://dx.doi.org/10.1371/journal.pone.0101720

Ejemplares similares